Vicore Pharma Holding AB (publ) (VCRE)
NASDAQ: VCRE · Real-Time Price · USD
9.90
-0.22 (-2.17%)
At close: Nov 18, 2026, 4:00 PM EST
10.13
+0.23 (2.32%)
After-hours: Nov 18, 2026, 4:10 PM EST
Vicore Pharma Holding AB Revenue
Vicore Pharma Holding AB had revenue of 594.00K SEK in the quarter ending September 30, 2026, a decrease of -21.84%. This brings the company's total for the last twelve months to 3.83M, down -54.97% year-over-year. In the year 2025, Vicore Pharma Holding AB had annual revenue of 3.82M, down -96.51%.
Revenue (ttm)
3.83M SEK
Revenue Growth
-54.97%
P/S Ratio
741.37
Revenue / Employee
76,560 SEK
Employees
50
Market Cap
278.12M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.82M | -105.53M | -96.51% |
| Dec 31, 2024 | 109.35M | - | - |
| Dec 31, 2023 | 0 | - | - |
| Dec 31, 2022 | 0 | - | - |
| Dec 31, 2021 | 0 | - | - |
| Dec 31, 2020 | 0 | - | - |
| Dec 31, 2019 | 0 | - | - |
| Dec 31, 2018 | 508.00K | -424.00K | -45.49% |
| Dec 31, 2017 | 932.00K | 80.00K | 9.39% |
| Dec 31, 2016 | 852.00K | 12.00K | 1.43% |
| Dec 31, 2015 | 840.00K | -11.00K | -1.29% |
| Dec 31, 2014 | 851.00K | 131.00K | 18.19% |
| Dec 31, 2013 | 720.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Autolus Therapeutics | 137.43M |
| Agenus | 133.95M |
| Century Therapeutics | 109.16M |
| Fulcrum Therapeutics | 80.00M |
| Precision BioSciences | 45.04M |
| Scribe Therapeutics | 14.83M |
| Allogene Therapeutics | 4.64M |
| Inhibikase Therapeutics | 1.00 |
VCRE News
- 6 days ago - Vicore Pharma Holding AB Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 8 days ago - Vicore Pharma Holding AB Slides: Corporate presentation - Filings
- 9 days ago - Vicore Pharma Holding AB Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 13 days ago - Vicore Pharma Holding AB Quarterly report: Q3 2026 - Filings
- 14 days ago - Vicore Pharma initiated with a Buy at Chardan - TheFly
- 23 days ago - Vicore Pharma Holding AB Slides: Company presentation - Filings
- 4 weeks ago - Vicore Pharma Holding AB Transcript: Chardan's 10th Annual Healthcare Conference - Transcripts
- 5 weeks ago - Vicore Pharma to Participate in the Chardan Healthcare Conference - Accesswire